HeeSoon Park - DongKook Pharmaceutical Managing Marketing
| 086450 Stock | KRW 16,610 30.00 0.18% |
Insider
HeeSoon Park is Managing Marketing of DongKook Pharmaceutical Co
| Age | 58 |
| Phone | (82) 2 566 8542 |
| Web | www.dkpharm.co.kr |
DongKook Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0608 % which means that it generated a profit of $0.0608 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 12.717 %, meaning that it generated $12.717 on every $100 dollars invested by stockholders. DongKook Pharmaceutical's management efficiency ratios could be used to measure how well DongKook Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 11 records | INSIDER Age | ||
| HyunHo Jung | Medy Tox | 61 | |
| Lopez Michael | Medy Tox | 62 | |
| HeeSeok Joo | Medy Tox | 57 | |
| YongIn Kim | Medy Tox | 61 | |
| Byeong Chong | LEENO Industrial | 59 | |
| Young Choi | LEENO Industrial | 56 | |
| Byung Kim | LEENO Industrial | 65 | |
| KiHyuk Yang | Medy Tox | 54 | |
| WooSun Lee | Medy Tox | 46 | |
| SeungBum Park | Medy Tox | 54 | |
| Tae Kim | LEENO Industrial | 65 | |
Management Performance
| Return On Equity | 12.72 | |||
| Return On Asset | 0.0608 |
DongKook Pharmaceutical Leadership Team
Elected by the shareholders, the DongKook Pharmaceutical's board of directors comprises two types of representatives: DongKook Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DongKook. The board's role is to monitor DongKook Pharmaceutical's management team and ensure that shareholders' interests are well served. DongKook Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DongKook Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gyeong Cha, Managing Director | ||
| GyuJin Lee, Managing Management | ||
| Bong Cho, Assistant Managing Director | ||
| HongKi Kim, Director Fin | ||
| Heung Oh, Chief Executive Officer, Director | ||
| Gi Kwon, Vice Chairman of the Board | ||
| Jae Park, Assistant Managing Director | ||
| HeeSoon Park, Managing Marketing | ||
| Mok Park, Managing Director | ||
| Se Jeon, Assistant Managing Director | ||
| Gi Jung, Managing Director | ||
| YoungWook Lee, Pres CEO | ||
| BongHo Cho, Managing Sales | ||
| Byeong Yoo, Managing Director | ||
| Seung Pyo, Assistant Managing Director | ||
| Gyu Jung, Internal Auditor | ||
| Hui Kim, Managing Director | ||
| Tae Kim, Assistant Managing Director | ||
| HeungJu Oh, VP CEO | ||
| SoonKang Hong, Managing PR | ||
| SeIl Jeon, Managing Sales | ||
| JoonHo Song, Managing Planning | ||
| JeWon Park, Managing Sales | ||
| Byeong Yeo, Director |
DongKook Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DongKook Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 12.72 | |||
| Return On Asset | 0.0608 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.08 T | |||
| Shares Outstanding | 8.79 M | |||
| Shares Owned By Insiders | 46.60 % | |||
| Shares Owned By Institutions | 17.00 % | |||
| Price To Earning | 19.52 X | |||
| Price To Sales | 0.24 X |
Other Information on Investing in DongKook Stock
DongKook Pharmaceutical financial ratios help investors to determine whether DongKook Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DongKook with respect to the benefits of owning DongKook Pharmaceutical security.